PCI Pharma Services
This role supports the Quality Assurance Manager in overseeing and improving Quality Management Systems at PCI Melbourne, ensuring compliance with regulatory requirements through the management of e-PQS software like MasterControl. The position involves driving continuous improvements, managing training and documentation, supporting investigations, and leading people management activities for direct reports within a pharmaceutical manufacturing environment.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
1001-5000 employees
PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success.
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala
Jul 14, 2025
PCI Pharma Services completes acquisition of Ajinomoto Althea
Aug 28, 2025
PCI Pharma Services Receives Strategic Investment from Bain Capital, Kohlberg and Mubadala
Sep 11, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PCI Pharma Services.
PCI Pharma Services didn’t post a salary, so this is our estimate from similar listings.
21% below the average for this role
Northeast Philadelphia’s PCI Pharma Services Receives Massive Investment, Now Valued At $10B
Jul 23, 2025
Manufacturing Quality Assurance Specialist, 3rd shift (Monday-Friday, 11 PM-7:30 AM)
AbbVie
Manufacturing Quality Assurance Specialist II
Kindeva Drug Delivery
Quality Assurance Specialist
Catalent
Quality Assurance Specialist
WuXi AppTec
Associate Quality Assurance
Integra LifeSciences
Manager, Quality Assurance Operations
Corcept Therapeutics